PROVIDER PROFILE · NPI 1639374549

Amal MehtaM.D.

PRACTICEC.V.MEHTA MD A MEDICAL CORP.See all providers at this practice →

RheumatologyHemet, CAI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

2,216

Unique beneficiaries

—

Total services

44,396

Distinct HCPCS

Medicare payment

$770K

Peer benchmark

Total Medicare services vs. 530 Rheumatology providers in CA — top quintile (cohort median 1,833).

PRESCRIBING · PART D · 2024

Total Rx claims

2,958

Beneficiaries

—

Total drug cost

$1.9M

Distinct drugs

Brand share

32.7%

Top prescribed drugs

Prednisone395 claims

Hydroxychloroquine Sulfate385 claims

Methotrexate Sodium341 claims

Hydrocodone/Acetaminophen145 claims

Gabapentin143 claims

QUALITY · MIPS · 2024

Final MIPS score

65.0

Quality

66.5

Cost

78.7

Improvement activities

40.0

Promoting interop.

0.0

Payment adjustment

-1.20%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$2K

Payment records

110

By payment type

Food and Beverage$2K

REFERRAL NETWORK

Where Amal Mehta's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 4 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Unilab Corporation Clinical Laboratory · West Hills, CA	89	230
Chandrakant Mehta Internal Medicine · Hemet, CA	37	73
William Kelly Diagnostic Radiology · Palm Desert, CA	24	42
Mvml, Inc. Clinical Laboratory · Hemet, CA	12	19

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history